One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

CNTA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.54%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $972,938.86

Centessa Pharmaceuticals Insider Trading History Chart

Centessa Pharmaceuticals Share Price & Price History

^$8.93

▼ -0.53 (-5.60%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

The Gold Grab of the Century

From Colonial Metals | Ad

When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.

Centessa Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/25/2024	Karen M Anderson	Insider	Sell	51,160	$11.88	$607,780.80	71,525
2/1/2024	Harris Rotman	SVP	Sell	4,267	$8.10	$34,562.70	62,625
9/20/2023	Harris Rotman	SVP	Sell	37,484	$6.29	$235,774.36	33,500
6/1/2023	Antoine Yver	EVP	Sell	6,500	$4.45	$28,925.00	783,066
5/24/2023	Tia L. Bush	Insider	Sell	8,000	$4.48	$35,840.00	157,102
5/1/2023	Antoine Yver	EVP	Sell	6,800	$4.42	$30,056.00	789,566
1/4/2023	Antoine Yver	EVP	Sell	6,970	$3.18	$22,164.60	751,913
12/1/2022	Antoine Yver	EVP	Sell	9,400	$3.91	$36,754.00	761,151
11/1/2022	Antoine Yver	EVP	Sell	9,700	$4.03	$39,091.00	765,059
10/3/2022	Antoine Yver	EVP	Sell	12,524	$3.92	$49,094.08	774,759
10/3/2022	David M Chao	Insider	Sell	4,167	$3.95	$16,459.65	222,932
10/3/2022	Gregory M Weinhoff	CFO	Sell	4,901	$3.95	$19,358.95	231,099
10/3/2022	Iqbal J Hussain	General Counsel	Sell	4,563	$3.95	$18,023.85	154,712
10/3/2022	Thomas Templeman	CTO	Sell	2,455	$3.95	$9,697.25	135,792
9/30/2022	Antoine Yver	EVP	Sell	2,468	$4.07	$10,044.76	787,283
9/30/2022	David M Chao	Insider	Sell	3,401	$4.07	$13,842.07	227,099
9/30/2022	Gregory M Weinhoff	CFO	Sell	4,000	$4.07	$16,280.00	236,000
9/30/2022	Iqbal J Hussain	General Counsel	Sell	3,725	$4.07	$15,160.75	159,275
9/30/2022	Thomas Templeman	CTO	Sell	2,003	$4.07	$8,152.21	138,247
8/1/2022	Antoine Yver	EVP	Sell	10,423	$4.45	$46,382.35	800,174
7/18/2022	Antoine Yver	EVP	Sell	20,000	$4.87	$97,400.00	810,597
7/1/2022	Antoine Yver	EVP	Sell	9,100	$5.03	$45,773.00	730,597
6/24/2022	Saurabh Saha	CEO	Buy	10,000	$4.63	$46,300.00	38,000
6/17/2022	Antoine Yver	EVP	Sell	9,200	$4.68	$43,056.00	739,697
5/17/2022	Antoine Yver	EVP	Sell	20,222	$5.42	$109,603.24	813,675
2/2/2022	Saurabh Saha	CEO	Buy	5,000	$9.74	$48,700.00
1/28/2022	David J. Grainger	Insider	Buy	27,500	$9.05	$248,875.00
12/2/2021	Medicxi Ventures Management (J	Major Shareholder	Buy	34,326	$12.82	$440,059.32
12/1/2021	Francesco De Rubertis	Director	Buy	60,304	$12.62	$761,036.48
11/30/2021	Medicxi Ventures Management (J	Major Shareholder	Buy	36,847	$11.62	$428,162.14
11/29/2021	Francesco De Rubertis	Director	Buy	56,706	$11.70	$663,460.20
11/26/2021	Francesco De Rubertis	Director	Buy	11,817	$11.34	$134,004.78
11/18/2021	Aaron Kantoff	Director	Buy	10,000	$11.98	$119,800.00
11/16/2021	Saurabh Saha	CEO	Buy	23,000	$12.28	$282,440.00
11/16/2021	Tia L. Bush	Insider	Buy	5,000	$12.46	$62,300.00

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

SEC Filings (Institutional Ownership Changes) for Centessa Pharmaceuticals (NASDAQ:CNTA)

82.01% of Centessa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Centessa Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/20/2024	Quarry LP	6,000	$48K	0.0%	N/A	0.006%
2/15/2024	Octagon Capital Advisors LP	2,060,100	$16.40M	2.6%	+333.2%	2.110%
2/15/2024	BVF Inc. IL	8,774,570	$69.85M	1.8%	-3.6%	8.988%
2/14/2024	Kynam Capital Management LP	442,704	$3.52M	0.4%	-39.4%	0.453%
2/14/2024	Platinum Investment Management Ltd.	381,083	$3.03M	0.1%	+12.9%	0.390%
2/13/2024	Affinity Asset Advisors LLC	795,729	$6.33M	1.2%	-21.8%	0.815%
2/9/2024	Franklin Resources Inc.	1,115,817	$8.88M	0.0%	+34.1%	1.143%
2/9/2024	Trexquant Investment LP	14,354	$0.11M	0.0%	N/A	0.015%
2/7/2024	Jump Financial LLC	14,300	$0.11M	0.0%	N/A	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	6,394	$51K	0.0%	+371.2%	0.007%
11/15/2023	Kynam Capital Management LP	730,472	$4.73M	0.8%	+0.2%	0.768%
11/15/2023	Acuta Capital Partners LLC	323,349	$2.09M	1.4%	N/A	0.340%
11/15/2023	Adage Capital Partners GP L.L.C.	2,830,500	$18.31M	0.0%	+25.8%	2.974%
11/15/2023	Affinity Asset Advisors LLC	1,018,091	$6.59M	1.9%	+13.0%	1.045%
11/13/2023	Rathbones Group PLC	31,300	$0.20M	0.0%	N/A	0.032%
11/3/2023	Platinum Investment Management Ltd.	337,544	$2.18M	0.1%	+96.7%	0.347%
10/27/2023	TD Asset Management Inc	186,310	$1.21M	0.0%	+127.1%	0.191%
8/21/2023	Affinity Asset Advisors LLC	900,723	$5.58M	1.9%	+31.7%	0.947%
8/11/2023	Platinum Investment Management Ltd.	171,625	$1.06M	0.0%	N/A	0.180%
8/3/2023	Tanager Wealth Management LLP	696,096	$4.31M	0.9%	-5.6%	0.728%
5/16/2023	BVF Inc. IL	9,423,215	$36.28M	1.3%	+36.7%	9.961%
5/15/2023	Affinity Asset Advisors LLC	684,127	$2.63M	0.9%	+48.6%	0.723%
5/15/2023	EcoR1 Capital LLC	5,618,779	$21.63M	0.7%	+7.4%	5.939%
5/15/2023	Sio Capital Management LLC	347,869	$1.34M	0.7%	N/A	0.368%
4/18/2023	Tanager Wealth Management LLP	737,059	$2.84M	0.7%	-60.8%	0.779%
2/14/2023	EcoR1 Capital LLC	5,232,279	$16.22M	0.5%	+61.7%	5.531%
1/27/2023	Tanager Wealth Management LLP	1,878,383	$5.82M	1.6%	N/A	1.986%
11/15/2022	Kynam Capital Management LP	731,521	$2.94M	0.6%	-3.5%	0.775%
11/15/2022	EcoR1 Capital LLC	3,236,352	$13.01M	0.4%	+1,007.1%	3.431%
11/15/2022	Ensign Peak Advisors Inc	248,228	$1M	0.0%	+101.7%	0.263%
11/14/2022	Cormorant Asset Management LP	1,972,728	$7.93M	0.6%	-32.6%	2.091%
11/14/2022	Point72 Asset Management L.P.	117,800	$0.47M	0.0%	-11.8%	0.125%
8/16/2022	Woodline Partners LP	1,314,652	$6.40M	0.1%	+48.9%	1.398%
8/12/2022	Ensign Peak Advisors Inc	123,071	$0.60M	0.0%	-61.1%	0.131%
8/12/2022	Franklin Resources Inc.	832,932	$4.06M	0.0%	+35.0%	0.886%
8/11/2022	Alps Advisors Inc.	55,785	$0.27M	0.0%	N/A	0.059%
8/4/2022	TD Asset Management Inc.	82,055	$0.40M	0.0%	+146.8%	0.087%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	57,342	$0.70M	0.0%	N/A	0.061%
5/13/2022	Kynam Capital Management LP	669,100	$6M	1.9%	+179.9%	0.712%
5/4/2022	OUP Management Co. LLC	2,937,615	$26.35M	20.1%	+25.4%	3.124%
2/19/2022	Woodline Partners LP	801,136	$9.02M	0.1%	-9.3%	0.891%
2/15/2022	Samsara BioCapital LLC	1,459,693	$16.44M	3.2%	-5.1%	1.624%
2/14/2022	Virtus ETF Advisers LLC	14,798	$0.17M	0.1%	N/A	0.016%
2/14/2022	Boxer Capital LLC	1,251,137	$14.09M	0.5%	-6.2%	1.392%
2/14/2022	Point72 Asset Management L.P.	1,097,908	$12.36M	0.0%	+263.3%	1.221%
2/14/2022	Deep Track Capital LP	400,000	$4.50M	0.3%	N/A	0.445%
2/14/2022	Affinity Asset Advisors LLC	419,144	$4.72M	1.7%	+106.3%	0.466%
2/11/2022	Ensign Peak Advisors Inc	343,292	$3.87M	0.0%	+19.9%	0.382%
2/9/2022	Compagnie Lombard Odier SCmA	5,820	$66K	0.0%	+111.6%	0.006%
2/7/2022	American Century Companies Inc.	517,123	$5.82M	0.0%	+39.7%	0.575%
2/3/2022	OUP Management Co. LLC	2,341,891	$26.37M	11.9%	N/A	2.605%
2/3/2022	Medicxi Ventures Management Jersey Ltd	18,123,892	$204.08M	51.1%	+1.1%	20.160%
11/16/2021	Janus Henderson Group PLC	5,607,302	$91.36M	0.0%	-1.3%	6.237%
11/16/2021	Brookfield Asset Management Inc.	26,788	$0.45M	0.0%	+45.6%	0.030%
11/16/2021	Millennium Management LLC	337,002	$5.63M	0.0%	-38.6%	0.375%
11/16/2021	Boxer Capital LLC	1,334,227	$22.28M	0.8%	+47.6%	1.484%
11/16/2021	Citadel Advisors LLC	349,548	$5.84M	0.0%	-23.4%	0.389%
11/15/2021	Point72 Asset Management L.P.	302,200	$5.05M	0.0%	+202.2%	0.336%
11/15/2021	RA Capital Management L.P.	3,577,094	$59.74M	0.8%	+179.4%	3.979%
11/15/2021	General Atlantic L.P.	9,681,818	$161.69M	0.9%	+545.5%	10.770%
11/15/2021	Ensign Peak Advisors Inc	286,404	$4.78M	0.0%	-18.2%	0.319%
11/12/2021	Affinity Asset Advisors LLC	203,183	$3.39M	0.9%	+203.5%	0.226%
11/12/2021	Ghisallo Capital Management LLC	15,000	$0.25M	0.0%	-40.0%	0.017%
11/10/2021	American Century Companies Inc.	370,292	$6.18M	0.0%	-0.3%	0.412%
11/9/2021	Jennison Associates LLC	296,456	$4.95M	0.0%	-1.2%	0.330%
10/28/2021	Compagnie Lombard Odier SCmA	2,750	$46K	0.0%	N/A	0.003%
8/25/2021	Marshall Wace North America L.P.	34,228	$0.76M	0.0%	N/A	0.038%
8/18/2021	Blackstone Inc	40,000	$0.89M	0.0%	N/A	0.044%
8/17/2021	Woodline Partners LP	822,518	$18.27M	0.3%	N/A	0.915%
8/17/2021	Samsara BioCapital LLC	1,537,533	$34.15M	4.2%	N/A	1.710%
8/17/2021	Brookfield Asset Management Inc.	18,404	$0.41M	0.0%	N/A	0.020%
8/17/2021	Logos Global Management LP	939,545	$20.87M	1.8%	N/A	1.045%
8/17/2021	Millennium Management LLC	548,452	$12.18M	0.0%	N/A	0.610%
8/17/2021	Price T Rowe Associates Inc. MD	2,011,073	$43.86M	0.0%	N/A	2.237%
8/17/2021	BVF Inc. IL	58,900	$1.31M	0.0%	N/A	0.066%
8/17/2021	Boxer Capital LLC	904,227	$20.08M	0.7%	N/A	1.006%
8/17/2021	Caas Capital Management LP	62,500	$1.39M	0.0%	N/A	0.070%
8/17/2021	Citadel Advisors LLC	456,233	$10.13M	0.0%	N/A	0.507%
8/16/2021	Squarepoint Ops LLC	37,771	$0.84M	0.0%	N/A	0.042%
8/16/2021	Point72 Asset Management L.P.	100,000	$2.22M	0.0%	N/A	0.111%
8/16/2021	Blackstone Inc	40,000	$0.89M	0.0%	N/A	0.044%
8/16/2021	RA Capital Management L.P.	1,280,300	$28.44M	0.5%	N/A	1.424%
8/16/2021	Tudor Investment Corp Et Al	43,079	$0.96M	0.0%	N/A	0.048%
8/16/2021	Avoro Capital Advisors LLC	500,000	$11.11M	0.2%	N/A	0.556%
8/13/2021	General Atlantic L.P.	1,500,000	$33.32M	0.2%	N/A	1.669%
8/13/2021	VR Adviser LLC	1,127,272	$25.04M	3.0%	N/A	1.254%
8/13/2021	Northern Trust Corp	18,400	$0.41M	0.0%	N/A	0.020%
8/13/2021	Affinity Asset Advisors LLC	66,957	$1.49M	0.5%	N/A	0.074%
8/13/2021	Franklin Resources Inc.	922,700	$20.49M	0.0%	N/A	1.026%
8/13/2021	Ensign Peak Advisors Inc	350,000	$7.77M	0.0%	N/A	0.389%
8/13/2021	Geode Capital Management LLC	9,513	$0.21M	0.0%	N/A	0.011%
8/13/2021	FMR LLC	790,000	$17.55M	0.0%	N/A	0.879%
8/12/2021	Vida Ventures Advisors LLC	3,931,818	$87.33M	21.9%	N/A	4.374%
8/12/2021	State of Wisconsin Investment Board	80,381	$1.79M	0.0%	N/A	0.089%
8/12/2021	JPMorgan Chase & Co.	2,090	$47K	0.0%	N/A	0.002%
8/12/2021	Jennison Associates LLC	300,000	$6.66M	0.0%	N/A	0.334%
8/12/2021	Monashee Investment Management LLC	130,000	$2.89M	0.3%	N/A	0.145%
8/5/2021	American Century Companies Inc.	371,504	$8.25M	0.0%	N/A	0.413%

Data available starting January 2016

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its pipeline products include SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of NT1 with potential expansion into other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; ZF874 in alpha-1 antitrypsin deficiency, a dual-STAT3/5 degrader program in acute myeloid leukemia (AML); MGX292, a protein-engineered variant of human bone morphogenetic protein 9 (BMP9) for the treatment of pulmonary arterial hypertension (PAH); and OX2R Agonists compounds are currently in development for the treatment of narcolepsy, including TAK-861. In addition, its products pipeline comprises CBS001, a neutralizing therapeutic mAb to the inflammatory membrane form of LIGHT for inflammatory / fibrotic diseases; and CBS004, a therapeutic mAb targeting BDCA-2 for the potential treatment of autoimmune diseases, as well as earlier-stage preclinical assets, including ORX750, an orally administered, selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and discovery-stage programs in certain other disease areas. Centessa Pharmaceuticals plc was incorporated in 2020 and is based in Altrincham, the United Kingdom.

Today's Range

Now: $8.93

$8.90

$9.39

50 Day Range

MA: $10.90

$8.93

$12.20

52 Week Range

Now: $8.93

$3.96

$12.45

Volume

286,486 shs

Average Volume

373,297 shs

Market Capitalization

$895.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.38

Who are the company insiders with the largest holdings of Centessa Pharmaceuticals?: Centessa Pharmaceuticals' top insider shareholders include:
Antoine Yver (EVP)
Gregory M Weinhoff (CFO)
David M Chao (Insider)
Iqbal J Hussain (General Counsel)
Tia L Bush (Insider)
Thomas Templeman (CTO)
Karen M Anderson (Insider)
Harris Rotman (SVP)
Saurabh Saha (CEO)
Learn More about top insider investors at Centessa Pharmaceuticals.

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

Get the name of the stock here >>>